Melanoma Drugs Market Trends

• Rising number of melanoma cases globally, is a significant driver of the market. Melanoma is one of the most aggressive forms of skin cancer and has been on the rise globally over the past few decades.
  
• For instance, as per the American Cancer Society, in 2023, there were an estimated 186,680 new cases of melanoma diagnosed in the U.S. Additionally, there were 7,990 deaths from melanoma in the same year.
  
• Factors such as excessive exposure to ultraviolet (UV) radiation from the sun, a history of sunburns, genetic predisposition, and a compromised immune system contribute to the increasing incidence.
  
• Thus, as the prevalence of melanoma grows, there is a greater demand for effective treatments. This has led to a surge in research and development activities aimed at discovering novel therapies and improving existing treatment options.
  
• Therefore, the expanding patient pool, coupled with advancements in drug development, is propelling the growth of the market.